Inventor · disambiguated record
Holly Maulhardt
Also filed as: MAULHARDT HOLLY
8 granted patents·6 pending applications·0 citations·filing 2018–2024
76Inventor score
Top patents by PatentIndex Score
14 records- 0186US12329858B2Local delivery of antineoplastic particles in combination with systemic delivery of immunotherapeutic agents for the treatment of cancerCRITITECH INC·Filed 2024·Granted Jun 17, 2025·0 cites·19 claims
- 0283US12128131B2Treatment of epithelial cysts by intracystic injection of antineoplastic particlesCRITITECH INC·Filed 2023·Granted Oct 29, 2024·0 cites·18 claims
- 0380US11918691B2Local delivery of antineoplastic particles in combination with systemic delivery of immunotherapeutic agents for the treatment of cancerCRITITECH INC·Filed 2023·Granted Mar 5, 2024·0 cites·14 claims
- 0480US11737972B2Treatment of epithelial cysts by intracystic injection of antineoplastic particlesCRITITECH INC·Filed 2022·Granted Aug 29, 2023·0 cites·18 claims
- 0573US11523983B2Treatment of epithelial cysts by intracystic injection of antineoplastic particlesCRITITECH INC·Filed 2021·Granted Dec 13, 2022·0 cites·18 claims
- 0673US2022331261A1Delivery of drug nanoparticles and methods of use thereofDFB SORIA LLC·Filed 2022·Application pending·0 cites
- 0770US11331278B2Delivery of drug nanoparticles and methods of use thereofDFB SORIA LLC·Filed 2020·Granted May 17, 2022·0 cites·24 claims
- 0870US2019254957A1Treatment of Epithelial Cysts by Intracystic Injection of Antineoplastic ParticlesCRITITECH INC·Filed 2019·Application pending·0 cites
- 0965US10918606B2Delivery of drug nanoparticles and methods of use thereofDFB SORIA LLC·Filed 2019·Granted Feb 16, 2021·0 cites·25 claims
- 1062US2024156861A1Cisplatin particles and uses thereofCRITITECH INC·Filed 2023·Application pending·0 cites
- 1161US2021214683A1Methods for isolating tumor-specific immune cells from a subject for adoptive cell therapy and cancer vaccinesCRITITECH INC·Filed 2019·Application pending·0 cites
- 1260US10449162B2Delivery of drug nanoparticles and methods of use thereofDFB SORIA LLC·Filed 2018·Granted Oct 22, 2019·0 cites·24 claims
- 1351US2019365700A1Methods for Isolating Tumor-Specific Immune Cells from a Subject for Adoptive Cell Therapy and Cancer VaccinesCRITITECH INC·Filed 2019·Application pending·0 cites
- 1444US2019365699A1Treatment of Kidney Tumors by Intratumoral Injection of Taxane ParticlesCRITITECH INC·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Holly Maulhardt files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →